No photo of Jenni Lahtela

Jenni Lahtela

  • PL 20 (Tukholmankatu 8)

    00014

    Finland

20092018
If you made any changes in Pure these will be visible here soon.

Publications 2009 2018

Filter
Article
2018

Absence of NEFL in patient-specific neurons in early-onset Charcot-Marie-Tooth neuropathy

Sainio, M. T., Ylikallio, E., Mäenpää, L., Lahtela, J. S. P., Mattila, P. M., Auranen, M., Palmio, J. & Tyynismaa, H., 5 Jun 2018, In : Neurology Genetics. 4, 3, 10 p., e244.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras-driven lung tumours

Närhi, K., Nagaraj, A. S., Parri, E., Turkki, R., van Duijn, P. W., Hemmes, A., Lahtela, J., Uotinen, V., Mäyränpää, M. I., Salmenkivi, K., Räsänen, J., Linder, N., Trapman, J., Rannikko, A., Kallioniemi, O., Af Hällström, T. M., Lundin, J., Sommergruber, W., Anders, S. & Verschuren, E. W., May 2018, In : Journal of Pathology. 245, 1, p. 101-113 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
2017

Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1

Nagaraj, A. S., Lahtela, J., Hemmes, A., Pellinen, T., Blom, S., Devlin, J. R., Salmenkivi, K., Kallioniemi, O., Mäyränpää, M., Narhi, K. & Verschuren, E. W., 17 Jan 2017, In : Cell Reports. 18, 3, p. 673-684 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File
2015

The putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis

Lahtela, J., Pradhan, B., Narhi, K., hemmes, A., Sarkioja, M., Kovanen, P. E., Brown, A. & Verschuren, E. W., Apr 2015, In : Disease Models & Mechanisms. 8, 4, p. 393-401 9 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File
2013

A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3

Lahtela, J., Corson, L. B., Hemmes, A., Brauer, M. J., Koopal, S., Lee, J., Hunsaker, T. L., Jackson, P. K. & Verschuren, E. W., 15 Feb 2013, In : Cell Cycle. 12, 4, p. 625-634 10 p.

Research output: Contribution to journalArticleScientificpeer-review

Solujen senesenssi uusien tuumorisuppressorigeenien tunnistamisessa

Lahtela, J., 2013, In : Solubiologi. 31, 1, p. 9-13 5 p.

Research output: Contribution to journalArticleProfessional

2011

Lethal evolution of a newborn with consistent features of hydrolethalus syndrome--Romanian patient

Belengeanu, V., Viskari, H., Tallila, J., Lahtela, J. S. P., Farcas, S., Andreescu, N., Stoian, M., Bohiltea, CL. & Fryns, JP., 2011, In : Genetic Counseling. 22, 3, p. 293-304.

Research output: Contribution to journalArticleScientificpeer-review

2010

Mutant CHUK and severe fetal encasement malformation

Lahtela, J. S. P., Nousiainen, H., Stefanovic, V., Tallila, J., Viskari, H., Karikoski, R., Gentile, M., Saloranta, C., Varilo, T. & Kestilä, M., 2010, In : New England Journal of Medicine. 363, 17, p. 1631-1637 7 p.

Research output: Contribution to journalArticleScientificpeer-review

2009

Unraveling the disease pathogenesis behind lethal hydrolethalus syndrome revealed multiple changes in molecular and cellular level

Honkala, H., Lahtela, J. S. P., Fox, H. M. A., Gentile, M., Pakkasjärvi, N. A., Salonen, R., Wartiovaara, K. J., Jauhiainen, M. & Kestilä, M., 2009, In : PathoGenetics. 2009, 2

Research output: Contribution to journalArticleScientificpeer-review